Currently, the diagnosis and prognosis of severity in SLE patients requires several laboratory investigations including the level of autoantibodies (anti-dsDNA, anti-Sm, etc.), complement C3, C4 in serum samples, and tissue biopsy for determination of immune complex accumulation in organs [6,7]. Here, C4A is linked to systemic lupus erythematosus.